HOME >> BIOLOGY >> NEWS
Early HIV treatment fails to restore memory T cells

Most of the bodys memory T cells vanish within weeks after a person is infected with the HIV virus. In a study from the Aaron Diamond AIDS Research Center and the Bernard-Nocht Institute appearing in the international open-access journal PLoS Medicine, researchers report that these memory T cells, mostly found in the digestive tract, tend not to return to normal even after years of treatment for HIV.

In recent years, HIV infection has been shown to deplete the bodys memory T cells quite rapidly. In particular, the memory cells in the intestinal lining are decimated within days, while the T cells usually measured in the blood fall much more gradually, typically over several years. Although T cells in the blood can return and remain at normal levels when HIV infection is treated with antiviral drugs, it has been unclear whether the intestinal mucosal memory cells return as well. By performing intestinal biopsies on volunteers who started HIV treatment shortly after infection, the researchers found that, unlike in blood, intestinal T cells remained low even after several years of HIV treatment in 70% of volunteers, even though only a tiny fraction of these cells were found to be expressing HIV. Furthermore, they found that the level of immune activation in the gastrointestinal tract remained elevated despite treatment.

The finding that intestinal immune cells do not return to normal in most people with HIV despite years of treatment raises the concern that clinical problems will result over time. Fortunately, this does not appear to be the case in most people currently being treated for HIV, some for as long as 10 years, but the results of this study suggest that vigilance is warranted for infections or other gastrointestinal problems resulting from prolonged impairment of immunity.

These results also suggest that treatments to preserve immune function early after infection should be studied, and in particular that an HIV vaccine may need to s
'"/>

Contact: Andrew Hyde
press@plos.org
44-122-346-3330
Public Library of Science
4-Dec-2006


Page: 1 2

Related biology news :

1. Early fire risk for mountains near Los Angeles
2. Early environmental exposure may accelerate age-related neurodegeneration
3. Early exposure to indoor fungus molecules may protect infants against future allergies
4. Early-stage sperm cells created from human bone marrow
5. Early Europeans unable to stomach milk
6. Early Earth haze may have spurred life, says University of Colorado study
7. Early detection
8. Early family experience can reverse the effects of genes, UCLA psychologists report
9. Early to bed, early to rise
10. Early exposure to synthetic estrogen puts DES Daughters at higher risk for breast cancer
11. Top researcher-educators receive Presidential Early Career Award for Scientists and Engineers

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/11/2019)... ... June 12, 2019 , ... With a ... plans to leverage the Geneious Biologics platform as a premium hub for bioinformatics ... at Abveris, says: “The Geneious team has done an excellent job accommodating our ...
(Date:6/4/2019)... (PRWEB) , ... June 04, 2019 , ... ... manufacturing of orthopedic medical devices, today announced Q1-19 revenues of $31M, up 12% ... combined with successful roll-out of strategic investments & operational excellence initiatives worldwide. , ...
(Date:6/3/2019)... (PRWEB) , ... June 03, 2019 , ... Stay on ... biotech, medical device and food industries. Access to all webinars is free, so be ... relevant in your field! , Visit http://www.xtalks.com to see our upcoming webinars: ...
Breaking Biology News(10 mins):
(Date:7/19/2019)... (PRWEB) , ... July 18, 2019 , ... ... known as “Ravi Everest,” will be joining forces with California-based charity Coalition Duchenne ... from July 20-22nd. Coalition Duchenne raises awareness and funding for Duchenne muscular dystrophy ...
(Date:7/17/2019)... ... July 16, 2019 , ... ... and manufacturing of Zolgensma® (onasemnogene abeparvovec-xioi), an AveXis gene therapy treatment for ... will have dedicated manufacturing space at the new, state-of-the-art commercial manufacturing center ...
(Date:7/11/2019)... ... , ... At the most recent stem cell training course in ... the R3 Heroes Program. The Veterans included individuals and families from all over the ... nominate a military Veteran, teacher or first responder to receive a regenerative therapy at ...
(Date:7/9/2019)... ... July 08, 2019 , ... Balluff has been named a ... the 2019 Innovative Product of the Year which highlights cutting-edge advancements and achievements ... Sensors Expo & Conference 2019, held this week in San Jose, California. ...
Breaking Biology Technology:
Cached News: